Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 16 for:    ketamine bipolar disorder
Previous Study | Return to List | Next Study

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

This study has suspended participant recruitment.
(Protocol Revisions)
Information provided by (Responsible Party):
Juvenile Bipolar Research Foundation Identifier:
First received: January 3, 2012
Last updated: September 4, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)